HQY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the investor's beginner level, long-term investment preference, and available capital, Healthequity Inc (HQY) is a good buy. The stock has strong long-term growth potential as indicated by analyst upgrades, positive congress trading activity, and a robust pipeline. Despite short-term bearish technical indicators and hedge fund selling, the long-term outlook remains favorable.
The technical indicators suggest a bearish short-term trend. The MACD is negatively expanding (-0.51), RSI is neutral at 34.877, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 85.181 and resistance at 87.561.
Analysts have consistently raised price targets, with the latest targets ranging from $105 to $125, citing strong operational leverage, AI deployment, and market share growth.
Congress trading data shows a recent purchase transaction of $0.8M, indicating confidence from influential figures.
The company is demonstrating strong HSA growth and operational efficiency.
Hedge funds are selling the stock, with a significant 213.73% increase in selling activity over the last quarter.
Short-term technical indicators are bearish, and the stock is trading below key pivot levels.
Financial data is unavailable for the latest quarter, but analysts have highlighted strong revenue and EBITDA performance in Q1, exceeding expectations.
Analysts maintain a positive outlook on HQY, with multiple upgrades and raised price targets. Recent upgrades highlight the company's ability to leverage AI, expand its pipeline, and achieve operational efficiency. The consensus is Outperform or Buy.
